Natsar Pharmaceuticals, Inc. funding

Natsar Pharmaceuticals, Inc., a pharmaceuticals company based in Ellicott City, MD, filed a Form D with the SEC on May 8, 2026 and reported $4.2M raised.

Amount raised$4.2M

Offering sizeOpen-ended

Filed with the SECMay 8, 2026

First saleApril 23, 2026

IndustryPharmaceuticals

SecuritiesEquity, Tenant-in-common

LocationEllicott City, MD

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far15

Minimum investment$1

Revenue rangeNo Revenues

View the original Form D on SEC EDGAR ↗ · All rounds filed May 8

Other health care rounds in Maryland

Kaigene, Inc.$55M · Oct 14Biotechnology Seraxis Holdings, Inc.$10M · Sep 24Biotechnology OS Therapies Inc$7.2M · Oct 23Biotechnology Templar Nova, Inc.$7M · Oct 7Biotechnology Accufy Diagnostics, Inc.$2M · Oct 28Biotechnology ColoWatch, Inc. /MD/$975K · Oct 8Other Health Care Drizzle Health, LLC$600K · Nov 10Biotechnology Terrace Systems, Inc.$250K · Sep 16Other Health Care